Related references
Note: Only part of the references are listed.Oligomeric alpha-synuclein and beta-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
Stephanie M. Williams et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane
El-Sayed Khafagy et al.
AAPS JOURNAL (2015)
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
Markus Mandler et al.
MOLECULAR NEURODEGENERATION (2015)
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
Nishant N. Vaikath et al.
NEUROBIOLOGY OF DISEASE (2015)
A Sensitive Phage-Based Capture ELISA for Sub-Femtomolar Detection of Protein Variants Directly from Biological Samples
Stephanie Williams et al.
BIOTECHNOLOGY PROGRESS (2015)
Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson's Disease
Md Shahaduzzaman et al.
PLOS ONE (2015)
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
Sofie Stalmans et al.
PLOS ONE (2015)
Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models
Wei Xin et al.
BIOMOLECULES (2015)
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
Markus Mandler et al.
ACTA NEUROPATHOLOGICA (2014)
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
Edward Rockenstein et al.
BRAIN (2014)
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
Dora Games et al.
JOURNAL OF NEUROSCIENCE (2014)
Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5-implications for dementia with Lewy bodies
Cassia R. Overk et al.
MOLECULAR NEURODEGENERATION (2014)
ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
Brian Spencer et al.
MOLECULAR THERAPY (2014)
Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
Veronica Lindstrom et al.
NEUROBIOLOGY OF DISEASE (2014)
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
Hien T. Tran et al.
CELL REPORTS (2014)
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
Nolwen L. Rey et al.
ACTA NEUROPATHOLOGICA (2013)
Axonopathy in an α-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal Truncated α-Synuclein
Dora Games et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Recombinant Single-Chain Antibody with the Trojan Peptide Penetratin Positioned in the Linker Region Enables Cargo Transfer Across the Blood-Brain Barrier
Nives Skrlj et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2013)
Caudo-rostral brain spreading of α-synuclein through vagal connections
Ayse Ulusoy et al.
EMBO MOLECULAR MEDICINE (2013)
Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies
Stefan Schildknecht et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD
Brian Spencer et al.
MOLECULAR THERAPY (2013)
TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson's Disease
Andreas Bender et al.
PLOS ONE (2013)
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Elvira Valera et al.
PHARMACOLOGY & THERAPEUTICS (2013)
scFv Antibody: Principles and Clinical Application
Zuhaida Asra Ahmad et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Cognitive deficits in a mouse model of pre-manifest Parkinson's disease
Iddo Magen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
Maria Jose Diogenes et al.
JOURNAL OF NEUROSCIENCE (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Prion-like acceleration of a synucleinopathy in a transgenic mouse model
Anne-Laure Mougenot et al.
NEUROBIOLOGY OF AGING (2012)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Kiren Ubhi et al.
JOURNAL OF NEUROSCIENCE (2010)
Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy - Implications for Excitotoxicity
Diana L. Price et al.
PLOS ONE (2010)
Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein
Sharareh Emadi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux
Roberta Marongiu et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases
Brian Spencer et al.
JOURNAL OF NEUROSCIENCE (2009)
The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice
Valentine Bouet et al.
NATURE PROTOCOLS (2009)
Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells
Bin Yuan et al.
NEUROSCIENCE LETTERS (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An scFv intrabody against the nonamyloid component of α-synuclein reduces intracellular aggregation and toxicity
Sandra M. Lynch et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Tiago Fleming Outeiro et al.
PLOS ONE (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Isolation of a human single chain antibody fragment against oligomeric α-synuclein that inhibits aggregation and prevents α-synuclein-induced toxicity
Sharareh Emadi et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Targeted delivery of proteins across the blood-brain barrier
Brian J. Spencer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo
Magali Periquet et al.
JOURNAL OF NEUROSCIENCE (2007)
Physiological and pathological properties of alpha-synuclein
G. K. Tofaris et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein
S. M. Fleming et al.
NEUROSCIENCE (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Production and purification of lentiviral vectors
Gustavo Tiscornia et al.
NATURE PROTOCOLS (2006)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein
C Zhou et al.
MOLECULAR THERAPY (2004)
Studies on the internalization mechanism of cationic cell-penetrating peptides
G Drin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Share Paper
